Treatment of Nonmetastatic Castration Resistant Prostate Cancer

被引：1
|
作者：
Luo, Jia [1 ]
Beer, Tomasz M. [2 ]
Graff, Julie N. [2 ,3 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
[3] VA Portland Hlth Care Syst, Portland, OR USA
来源：
ONCOLOGY-NEW YORK | 2016年 / 30卷 / 04期
关键词：
METASTASIS-FREE SURVIVAL; ANDROGEN-RECEPTOR GENE; ANTIANDROGEN WITHDRAWAL; PHASE-III; MEN; THERAPY; HORMONE; ENZALUTAMIDE; BICALUTAMIDE; COMBINATION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Patients with nonmetastatic castration-resistant prostate cancer (CRPC) are a heterogeneous population with regard to risk of progression to metastatic disease. Treatment selection for nonmetastatic CRPC must balance the risk of disease progression with the side effects of available therapies. Several medication classes are available for use in treating these patients, and other newer agents are under active clinical trial investigation. Here we review current therapies for nonmetastatic CRPC and discuss the recently completed and ongoing trials for this emerging disease state.
引用
收藏
页码：336 / 344
页数：9
相关论文
共 50 条
  • [1] Management of nonmetastatic castration-resistant prostate cancer
    Traboulsi, Samer L.
    Saad, Fred
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (03) : 366 - 371
  • [2] Influence of modern diagnosticmethods on the treatment of nonmetastatic castration-resistant prostate cancer
    Kretschmer, A.
    Tilki, D.
    UROLOGE, 2019, 58 (05): : 529 - 534
  • [3] Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer
    Altavilla, Amelia
    Casadei, Chiara
    Lolli, Cristian
    Menna, Cecilia
    Ravaglia, Giorgia
    Gurioli, Giorgia
    Farolfi, Alberto
    Brighi, Nicole
    Conteduca, Vincenza
    Burgio, Salvatore Luca
    Schepisi, Giuseppe
    Rossi, Lorena
    Gargiulo, Stefania
    Lisotti, Ivana
    De Giorgi, Ugo
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2091 - 2099
  • [4] Managing Nonmetastatic Castration-resistant Prostate Cancer
    Mateo, Joaquin
    Fizazi, Karim
    Gillessen, Silke
    Heidenreich, Axel
    Perez-Lopez, Raquel
    Oyen, Wim J. G.
    Shore, Neal
    Smith, Matthew
    Sweeney, Christopher
    Tombal, Bertrand
    Tomlins, Scott A.
    de Bono, Johann S.
    EUROPEAN UROLOGY, 2019, 75 (02) : 285 - 293
  • [5] Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity
    Lopez-Campos, Fernando
    Conde-Moreno, Antonio
    Barrado Los Arcos, Marta
    Gomez-Caamano, Antonio
    Garcia-Gomez, Raquel
    Hervas Moron, Asuncion
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [6] Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction
    Esther, John
    Maughan, Benjamin L.
    Anderson, Neysi
    Agarwal, Neeraj
    Hahn, Andrew W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (02)
  • [7] Systemic Management for Nonmetastatic Castration-resistant Prostate Cancer A Systematic Review and Network Meta-Analysis
    Liu, Zefu
    Zhang, Tong
    Ma, Zikun
    Zheng, Shiyang
    Chen, Junying
    Wu, Zhiming
    Zheng, Xia
    Li, Xiangdong
    Liu, Zhuowei
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (04): : 288 - 297
  • [8] Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
    Hussain, Maha
    Fizazi, Karim
    Saad, Fred
    Rathenborg, Per
    Shore, Neal
    Ferreira, Ubirajara
    Ivashchenko, Petro
    Demirhan, Eren
    Modelska, Katharina
    Phung, De
    Krivoshik, Andrew
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (26) : 2465 - 2474
  • [9] Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
    Sternberg, Cora N.
    Fizazi, Karim
    Saad, Fred
    Shore, Neal D.
    De Giorgi, Ugo
    Penson, David F.
    Ferreira, Ubirajara
    Efstathiou, Eleni
    Madziarska, Katarzyna
    Kolinsky, Michael P.
    Cubero, Daniel I. G.
    Noerby, Bettina
    Zohren, Fabian
    Lin, Xun
    Modelska, Katharina
    Sugg, Jennifer
    Steinberg, Joyce
    Hussain, Maha
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23) : 2197 - 2206
  • [10] Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide
    Fizazi, Karim
    Shore, Neal
    Tammela, Teuvo L.
    Ulys, Albertas
    Vjaters, Egils
    Polyakov, Sergey
    Jievaltas, Mindaugas
    Luz, Murilo
    Alekseev, Boris
    Kuss, Iris
    Le Berre, Marie-Aude
    Petrenciuc, Oana
    Snapir, Amir
    Sarapohja, Toni
    Smith, Matthew R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11) : 1040 - 1049
12345